Side-effects are unwanted symptoms, discomfort or more serious adverse (harmful) consequences of drug treatment. Serious side-effects are rare in patients taking anti-TB drugs. A minority of TB patients treated with Category I or Category II regimens experience adverse side-effects categorised as:

Possible side-effects of the anti-TB drugs and their management are listed in the following table:

Symptom-based approach to management of anti-TB drug side-effects

Side-effectsDrugsManagement

(a) Minor (continue anti-TB drugs)

Decreased appetite, nausea, abdominal pain rifampicin pyrazinamide Give tablets with small meals or last thing at night
Joint pains pyrazinamide Aspirin
Burning sensation in the feet isoniazid Pyridoxine 100 mg daily
Orange/red urine rifampicin Reassurance; symptom is harmless
Itching, skin rash streptomycin; rifampicin or isoniazid Refer to higher health facility where TB treatment is available

(b) Major (stop the drug(s) responsible)

Deafness streptomycin Refer to higher health facility where TB treatment is available
Dizziness (vertigo, imbalance and loss of balance) streptomycin Refer to higher health facility where TB treatment is available
Yellowish discoloration of the eye (hepatitis) most anti-TB drugs Refer to higher health facility where TB treatment is available
Vomiting and confusion most anti-TB drugs Refer to higher health facility where TB treatment is available
Visual impairment ethambutol Refer to higher health facility where TB treatment is available
Shock, skin rash and decreased urine output rifampicin Refer to higher health facility where TB treatment is available

In the next study session we turn to the subject of following-up patients and tracing patients who are not taking their medication.